Related Experiment Video
Updated: May 2, 2026

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
Disulfide linkages in Plasmodium falciparum plasmepsin-i are essential elements for its processing activity and
Sirisak Lolupiman1, Pilaiwan Siripurkpong2, Jirundon Yuvaniyama1
1Department of Biochemistry and Center for Excellence in Protein Structure and Function, Faculty of Science, Mahidol University, Bangkok, Thailand.
Abstract:
Plasmodium falciparum plasmepsin-I (PM-I) has been considered a potential drug target for the parasite that causes fatal malaria in human. Determination of PM-I structures for rational design of its inhibitors is hindered by the difficulty in obtaining large quantity of soluble enzyme. Nearly all attempts for its heterologous expression in Escherichia coli result in the production of insoluble proteins in both semi-pro-PM-I and its truncated form, and thus require protein refolding. Moreover, the yields of purified, soluble PM-I from all reported studies are very limited. Exclusion of truncated semi-pro-PM-I expression in E. coli C41(DE3) is herein reported. We also show that the low preparation yield of purified semi-pro-PM-I with autoprocessing ability is mainly a result of structural instability of the refolded enzyme in acidic conditions due to incomplete formation of disulfide linkages. Upon formation of at least one of the two natural disulfide bonds, nearly all of the refolded semi-pro-PM-I could be activated to its mature form. A significantly improved yield of 10 mg of semi-pro-PM-I per liter of culture, which resulted in 6-8 mg of the mature PM-I, was routinely obtained using this strategy.
Insights
Researchers improved the yield of soluble Plasmodium falciparum plasmepsin-I (PM-I), a malaria drug target, by optimizing protein refolding and disulfide bond formation. This strategy enables better structural studies for rational drug design against malaria.
Area of Science:
- Biochemistry
- Parasitology
- Structural Biology
Background:
- Plasmodium falciparum plasmepsin-I (PM-I) is a potential drug target for treating human malaria.
- Obtaining soluble PM-I for structural studies is challenging due to difficulties in heterologous expression and low yields.
Purpose of the Study:
- To develop a strategy for improved yield of soluble, active PM-I.
- To facilitate structural determination of PM-I for rational inhibitor design.
Main Methods:
- Optimized heterologous expression of semi-pro-PM-I in E. coli C41(DE3).
- Investigated protein refolding conditions, focusing on disulfide bond formation.
- Assessed autoprocessing and activation of refolded PM-I.
Main Results:
- Successfully excluded truncated semi-pro-PM-I expression.
- Identified structural instability in acidic conditions due to incomplete disulfide bonds as a cause of low yield.
- Achieved significantly improved yields of 10 mg/L semi-pro-PM-I, yielding 6-8 mg/L mature PM-I.
Conclusions:
- Optimized refolding and disulfide bond formation strategies enhance soluble PM-I yield.
- This improved yield facilitates structural studies and drug development for malaria.
- The strategy overcomes previous limitations in obtaining sufficient quantities of active PM-I.
Related Concept Videos
Sulfur Assimilation
Production of Pharmaceuticals

